Bukalapakcom Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bukalapakcom Tbk trades at Rp114 (market cap 11.55T, 45.77M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp238 (market cap 164.65B, 50.3K 24h volume). The key difference: Bukalapakcom Tbk is far larger — about 70.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bukalapakcom Tbk is more actively traded (45.77M versus 50.3K). Which is the better fit depends on your goals.
| BUKA | OBAT | |
|---|---|---|
Market Cap | 11.55T | 164.65B |
Volume | 45.77M | 50.3K |
Lot | 457.72K | 503 |
Turnover | 5.24B | 12.13M |
Average Price | 114.56 | 241.18 |
Value | 5.24B | 12.13M |
Indicative Equilibrium Price | 111 | 238 |
Indicative Equilibrium Volume | 1.4K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bukalapak.com Tbk. (the Company) was established in Indonesia on September 9, 2011 based on Notarial Deed No. 11 on the same date of Dr. Misahardi Wilamarta, S.H., M.H., M.Kn., LL.M.
Read more on BUKA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →